Ticagrelor vs Clopidogrel Effect on MFR in CAD Population

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Coronary Artery Disease
Interventions
DRUG

Ticagrelor

Blinded administration of ticagrelor for 10 days

DRUG

Clopidogrel

Blinded administration of clopidogrel and placebo for 10 days

Trial Locations (1)

K1Y 4W7

University of Ottawa Heart Institute, Ottawa

All Listed Sponsors
lead

Ottawa Heart Institute Research Corporation

OTHER

NCT01894789 - Ticagrelor vs Clopidogrel Effect on MFR in CAD Population | Biotech Hunter | Biotech Hunter